Manufacturing, Monoclonal Antibodies

>

Latest News

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com
Shilpa Biologicals Partners with mAbTree Biologics to Develop and Commercialize a Novel Immuno-Oncology Asset

March 17th 2025

Under the agreement, Shilpa will undertake development and commercial supply for a novel checkpoint inhibitor for immuno-oncology indications.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Regeneron Receives Positive Opinion from EMA for Relapsed and Refractory Multiple Myeloma

March 4th 2025

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com
Bora Biologics to Support DotBio’s Novel Antibody Against Cancer Targets

January 10th 2025

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Sanofi Invests €40 Million to Boost Antibody Production in France

November 21st 2024

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
Lonza’s Synaffix and BigHat Biosciences Team Up on Machine Learning-Designed ADCs

November 6th 2024

More News

Downstream Processing of Monoclonal Antibodies: from High Dilution to High Purity

Downstream Processing of Monoclonal Antibodies: from High Dilution to High Purity

Uwe Gottschalk, PhD
June 1st 2005

In a mere 30 years of development, a total of 23 MAbs and MAb-related proteins have been approved for medical treatments.

<1
...
678910
© 2025 MJH Life Sciences

All rights reserved.